91004-60-3

Basic information

• Product Name: 5-HYDRAZINOQUINOLINE DIHYDROCHLORIDE
• Synonyms: 5-HYDRAZINOQUINOLINE DIHYDROCHLORIDE;5-Hydrazinoquinoline2HCl;5-hydrazinylquinoline hydrochloride;1-(QUINOLIN-5-YL)HYDRAZINE 2HCL
• CAS NO: 91004-60-3
• Molecular Formula: C₉H₉N₃*2ClH
• Molecular Weight: 232.11
• Mol File: 91004-60-3.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 424.3 °C at 760 mmHg
• Flash Point: 210.4 °C
• Appearance: /
• CAS DataBase Reference: 5-HYDRAZINOQUINOLINE DIHYDROCHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-HYDRAZINOQUINOLINE DIHYDROCHLORIDE(91004-60-3)
• EPA Substance Registry System: 5-HYDRAZINOQUINOLINE DIHYDROCHLORIDE(91004-60-3)

Safety Data

• Hazardous Substances Data: 91004-60-3(Hazardous Substances Data)

Upstream product

• 15793-79-0 quinolin-5-yl-hydrazine 
• 611-34-7 5-Aminoquinoline 
• 50-81-7 ascorbic acid 

Downstream Products

• 102852-58-4 4-methoxycyclohexanone 5-quinolylhydrazone 
• 233-36-3 1H-pyrrolo[2,3-f]quinoline 

Relevant articles and documents

The synthesis of 4-(3,3-dimethyl-3H-pyrrolo[2,3-f] quinolin-2-yl)pyrazoles and 4-(3,3-dimethyl-3H-pyrrolo[3,2-h] quinolin-2-yl)pyrazoles

(Chemical Equation Presented) 5-Hydrazinoquinoline and 8-hydrazinoquinoline were converted via Fischer syntheses with 3-methylbutan-2-one into pyrido-indolenines 2,3,3-trimethyl-3H-pyrrolo[2,3-f]quinoline 7 and 2,3,3-trimethyl-3H-pyrrolo[ 3,2-h]quinoline 11, respectively. Exposure of the indolenines to the Vilsmeier reagent produced aminomethylene-malondialdehydes 8 and 12, which reacted with hydrazine or arylhydrazines to give 4-(3H-pyrrolo[2,3-f]quinolin-2-yl)- and 4-(3H-pyrrolo[3,2-h]quinolin-2-yl)- pyrazoles, 9 and 13.

ACYLHYDRAZIDE P2X7 ANTAGONISTS AND USES THEREOF

The present invention discloses a compound of formula (I) or a pharmaceutically acceptable salt or prodrug thereof, wherein D, A, m, n, Rx and Ry are defined in the description. The present invention also relates to pharmaceutical compositions of compound

Preparation of sodium-hydrogen exchanger type-1 inhibitors

This invention relates to methods of preparing sodium-hydrogen exchanger type 1 (NHE-1) inhibitors of formula I′ 1intermediates of the NHE-1 inhibitors and a new almost colorless form of the NHE-1 inhibitor N-(5-cyclopropyl-1-quinolin-5-yl-1H-pyrazole-4-carbonyl)-guanidine.